Key regions: United States, Germany, Australia, India, United Kingdom
The Sleep Aids (Pharmacies) market in Europe is experiencing significant growth and development.
Customer preferences: Customers in Europe are increasingly seeking sleep aids to help them combat sleep disorders and improve their overall quality of sleep. The busy and stressful lifestyles of Europeans, combined with the prevalence of technology and screens, have led to a rise in sleep-related issues. As a result, there is a growing demand for sleep aids in the region.
Trends in the market: One of the key trends in the Sleep Aids (Pharmacies) market in Europe is the growing popularity of natural and herbal sleep aids. Customers are becoming more conscious of the potential side effects of traditional sleep aids and are seeking alternative options. Natural sleep aids, such as melatonin supplements and herbal teas, are gaining traction as customers look for safer and more sustainable solutions. Another trend in the market is the increasing availability of sleep aids in pharmacies. Pharmacies are expanding their product offerings to cater to the rising demand for sleep aids. This allows customers to conveniently access sleep aids and seek professional advice from pharmacists. Pharmacies are also leveraging their trusted reputation to promote sleep aids and educate customers about the importance of sleep hygiene.
Local special circumstances: In certain European countries, such as Germany and France, there are regulations in place that restrict the sale of certain sleep aids without a prescription. This creates a unique market dynamic where customers have limited access to over-the-counter sleep aids and need to consult a healthcare professional before purchasing sleep aids. This regulatory environment impacts the availability and sales of sleep aids in these countries.
Underlying macroeconomic factors: The growing Sleep Aids (Pharmacies) market in Europe can be attributed to several macroeconomic factors. Firstly, the increasing prevalence of sleep disorders and sleep-related issues is driving the demand for sleep aids. As the awareness and understanding of the importance of sleep grow, more customers are seeking solutions to improve their sleep quality. Secondly, the aging population in Europe is also contributing to the growth of the Sleep Aids (Pharmacies) market. Older individuals are more prone to sleep disorders and are actively seeking sleep aids to address their sleep issues. The aging population in Europe is expected to continue growing, further fueling the demand for sleep aids. Lastly, the rise in disposable income in Europe is enabling customers to afford sleep aids. As people become more financially stable, they are willing to invest in products that can enhance their well-being, including sleep aids. This increased purchasing power is driving the sales of sleep aids in the region. In conclusion, the Sleep Aids (Pharmacies) market in Europe is experiencing growth and development due to customer preferences for sleep aids, the availability of natural and herbal sleep aids, the expanding product offerings in pharmacies, local regulations, and underlying macroeconomic factors such as the prevalence of sleep disorders, the aging population, and rising disposable income.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
